IP Library Granted Patent US 9,234,197
Granted Patent B2
US 9,234,197 · App. 14/349,835 · Granted Jan 12, 2016

Genetic element that enhances protein translation

Inventors: John Chaput (Phoenix, AZ); Bertram Jacobs (Tempe, AZ); Brian Wellensiek (Glendale, AZ); Julia Flores (Mesa, AZ)
Assignee: Arizona Board of Regents, A Body Corporate of the State of Arizona for and on Behalf of Arizona State University
C12N15/113C12N15/67C12N15/85C12N2830/30C12N2830/85C12N2840/105C12N2840/85
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,234,197
App. No.
14/349,835
Granted
Jan 12, 2016
Kind
B2
Abstract

The present invention provides isolated polynucleotides that can serve as translation enhancing elements and their use in protein expression reagents and methods.

Claims (15)

1. A recombinant viral or plasmid expression vector comprising

(a) a translation enhancement element (TEE) of between 37 and 42 nucleotides in length, comprising the nucleic acid sequence of 5′-CATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO: 1); and

(b) a cloning site located downstream of the TEE.

2. The expression vector of claim 1 , further comprising a promoter located upstream of the TEE.

3. The expression vector of claim 1 , further comprising a protein encoding nucleic acid cloned into the cloning site.

4. An isolated recombinant host cell comprising the expression vector of claim 1 .

5. A method for protein expression, comprising contacting the expression vector of claim 3 with reagents and under conditions for promoting expression of the protein encoded by the protein-encoding nucleic acid, and expressing the protein.

6. The method of claim 5 , wherein the protein is expressed in a cell-free translation system.

7. The method of claim 5 , wherein the protein is expressed by a recombinant host cell.

8. The method of claim 5 , wherein the expression vector is a recombinant vaccinia virus.

9. The method of claim 7 , wherein the recombinant host cell expresses the protein using non-viral-mediated translation.

10. An isolated recombinant virus, comprising the expression vector of claim 1 , wherein the expression vector is comprises a viral expression vector.

11. The recombinant virus of claim 10 , wherein the recombinant virus is a vaccinia virus, and the viral expression vector is a vaccinia virus expression vector.

12. The expression vector of claim 1 , wherein the TEE consists of 5′-CATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO: 1).

13. The expression vector of claim 1 , wherein the TEE consists of 5′-AGAACCATATTGAAGAGACAGAGTGATATATAAAACTGCTAA-3′ (SEQ ID NO:2).

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 19, 2015
From: ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035045/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2014
From: CHAPUT, JOHN; JACOBS, BERTRAM; WELLENSIEK, BRIAN; FLORES, JULIA
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 032630/0957 →
Continuity (2)
Provisional Application 61552564 · Oct 28, 2011
Related Publication 20140255990A1 · Sep 11, 2014